Pancreatic cancer
No one can tell you exactly how long you will live.
Below are general statistics based on large groups of people. Remember, they can’t tell you what will happen in your individual case.
The terms 1 year survival, 3 year survival and 5 year survival don't mean that you will only live for 1, 3 or 5 years.
Statisticians and researchers collect information. They watch what happens to people with cancer in the years after their diagnosis. 5 years is a common time point to measure survival. But some people live much longer than this.
5 year survival is the number of people who have not died from their cancer within 5 years after diagnosis.
There are different types of pancreatic cancer. Most pancreatic cancers are the exocrine type. This means that they start in cells that produce pancreatic digestive juices. The survival information in this section excludes survival by stage for pancreatic endocrine tumours. This can be found further down this page.
The information below comes from a large study looking at the cancer registries of 7 countries. Cancer registries collect information about a person’s cancer directly from hospitals and healthcare professionals.
The information about survival by stage is for people diagnosed with pancreatic cancer between 2012 and 2014.
This study included the UK. The researchers excluded Scotland from the UK nations as there was missing stage information. So, the following information is based on England, Wales and Northern Ireland.
The statistics are split into 3 stage groups – localised, regional and distant cancers. In the UK, your doctor might not use these terms. Instead, they might describe your cancer as a number stage (stage 1 to 4). The following descriptions are a guide to help you understand whether your cancer is localised, regional or distant. This isn’t always straight forward and will depend on your individual situation. Talk to your specialist if you are unsure which group you are in.
Localised cancer means your cancer has not spread beyond the pancreas
Regional cancer means your cancer has spread to nearby lymph nodes
Distant cancer means your cancer has spread to another part of your body
Almost 55 out of 100 people (almost 55%) survive their cancer for 1 year or more after diagnosis.
More than 25 out of 100 people (more than 25%) survive their cancer for 3 years or more after diagnosis.
Around 50 out of 100 people (around 50%) survive their cancer for 1 year or more after diagnosis.
Around 15 out of 100 people (around 15%) survive their cancer for 3 years or more after diagnosis.
Around 10 out of 100 people (around 10%) survive their cancer for 1 year or more after diagnosis.
Only 1 out of 100 people (1%) survive their cancer for 3 years or more after diagnosis.
The UK survival statistics come from England and Wales. Scotland and Northern Ireland have a similar population and health care system. So we can apply these survival statistics to the whole of the UK.
Generally for adults with pancreatic cancer in the UK:
25 out of every 100 (25%) survive their cancer for 1 year or more
more than 5 out of every 100 (more than 5%) survive their cancer for 5 years or more
around 5 out of every 100 (around 5%) survive their cancer for 10 years or more
One reason for the poor outlook for pancreatic cancer is that it is often diagnosed late. The cancer is very often quite advanced.
Only around 10 in 100 people (around 10%) can have surgery to remove pancreatic cancer, which gives the best chance of cure.
Pancreatic endocrine tumours are an uncommon type of pancreatic cancer. More recently doctors have been calling them neuroendocrine neoplasms (NENs). This is an umbrella term for this group of disorders. Then they are called either neuroendocrine tumours (NETs) or neuroendocrine carcinomas (NECs). This depends on how slow or fast growing the cells are.
They generally have a better outlook than adenocarcinoma of the pancreas.
Read more about neuroendocrine tumours
The information below is for 1 year overall survival for pancreatic neuroendocrine neoplasms (NENs) in the UK.
Around 80 in 100 people (around 80%) survive for 1 year or more.
There are no UK-wide 5 year survival statistics available for pancreatic NENs. The statistics below are from a European study. Please be aware that these figures may not be a true picture of survival in the UK. This is due to differences in health care systems, data collection and the population,
Around 40 out of 100 people (around 40%) survive their cancer for 5 years or more after diagnosis.
Your outlook depends on the stage of the cancer when it was diagnosed. This means how big it is and whether it has spread.
The type of cancer and grade of the cancer cells can also affect your likely survival. Grade means how abnormal the cells look under the microscope.
Your general health and fitness also affect survival. This is because the fitter you are, the better you may be able to cope with your cancer and treatment.
For more in-depth information about survival and other statistics for pancreatic cancer, go to our Cancer Statistics section.
Last reviewed: 09 Feb 2023
Next review due: 09 Feb 2026
Stage means the size of the cancer and whether it has spread. Type means the type of cell it started from. Grade means how abnormal the cells look. Knowing this information helps doctors decide about treatment.
Most people are diagnosed with pancreatic cancer after they become unwell and go to A&E. Others start by seeing their GP. Find out what to expect when you see a GP and tests you might have.
Your treatment depends on the position of the cancer in the pancreas, how big it is, the type of pancreatic cancer it is, whether it has spread, if they can remove it with surgery and your general health.
Get practical and emotional support to help you cope with a diagnosis of pancreatic cancer, and life during and after treatment.
Pancreatic cancer is cancer that starts in the pancreas. The pancreas is a gland that produces digestive juices and hormones. Find out about symptoms, tests you might have to diagnose it, treatment and about living with it.
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
